Showing results (61-70 of 685) with videos related to
Sort By:
Pageof 69
Bone Marrow Transplantation|June 1, 1995
Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?J E Peacock, C M Greven, J M Cruz, et al.Medical and Pediatric Oncology|January 1, 1981
VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic featuresD D Hurd, B A Peterson, R W McKenna, et al.American Journal of Hematology|February 1, 1990
Prognostic factors at relapse for adults with acute myeloid leukemiaD L Uhlman, C D Bloomfield, D D Hurd, et al.Reviews of Infectious Diseases|November 1, 1989
Profound muscle weakness as the presenting feature of disseminated cryptococcal infectionD D Hurd, D B Staub, R I Roelofs, et al.British Journal of Haematology|October 1, 1982
Reversal of severe bone marrow fibrosis and osteosclerosis following allogeneic bone marrow transplantation for chronic granulocytic leukaemiaP B McGlave, R D Brunning, D D Hurd, et al.Techniques in Urology|August 30, 2000
Are coagulation studies necessary before percutaneous nephrostomy?J H Martin, C J Rosser, R F Linebach, et al.The Journal of Urology|February 1, 1985
Pediatric anatrophic nephrolithotomyD G Assimos, W H Boyce, L H Harrison, et al.The Journal of Urology|March 1, 1991
Spontaneous perinephric hemorrhage: imaging and managementR J Zagoria, R B Dyer, D G Assimos, et al.The Journal of Urology|June 1, 1986
Postoperative anatrophic nephrolithotomy bleedingD G Assimos, W H Boyce, L H Harrison, et al.Breast Cancer Research and Treatment|February 1, 1997
Tamoxifen as initial endocrine therapy for metastatic breast cancer: long term follow-up of two Piedmont Oncology Association (POA) trialsJ T Kuss, H B Muss, H Hoen, et al.Pageof 69